Pablo Moral
Dr Pablo Moral is a scientist and Project Leader in Global Health Medicines R&D at GSK. Following academic research in Spain and the United States, he has spent the past seven years working to advance new approaches to tackling antimicrobial resistance (AMR). His research focuses on understanding how pathogens evade the immune system and developing new antimicrobials. Within the END2AMR consortium, he leads Work Package 2, working with international researchers to explore bacteriophage-derived proteins as potential new therapies for difficult-to-treat bacterial infections.
-
An expert's opinion: Interview with Dr Pablo Moral on the fight against antimicrobial resistance
Dr Pablo Moral is a bioscientist working at GSK Global Health Medicines. As the industrial lead of the EU-funded END2AMR project, a European consortium launched in 2026 to pioneer novel therapies against drug-resistant pathogens, Dr. Moral stands at the forefront of the fight against antimicrobial resistance,... -
European Antibiotic Awareness Day turns 18: What have we learnt so far?
Since the discovery of bacterial infections in the first half of the 20th century, humanity has relied on the great healing capabilities of antibiotics as a cornerstone of modern medicine - perhaps too heavily. Excessive antibiotic consumption has accelerated antimicrobial resistance (AMR) in bacteria,...